DIETARY MINERALS AND FATS IN BREAST CANCER
膳食矿物质和脂肪与乳腺癌的关系
基本信息
- 批准号:3167779
- 负责人:
- 金额:$ 12.07万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1980
- 资助国家:美国
- 起止时间:1980-04-01 至 1986-11-30
- 项目状态:已结题
- 来源:
- 关键词:benzanthracenes blood tests breast neoplasms butylated hydroxytoluene carcinogenesis inhibitor cellular oncology chemical carcinogenesis diet therapy dietary lipid dietary supplements dietary trace element fluorimetry glutathione peroxidase methionine nutrition related tag peroxidation saturated fat sectioning selenium stainings tissue /cell preparation tocopherols unsaturated fats vegetable oils
项目摘要
It is the objective of this proposal to continue studies on the
anticarcinogenic action of selenium in mammary neoplasia and to determine
how the feeding of a high-fat diet can alter the chemopreventive efficacy
of selenium. Our investigation involves the dimethylbenz(a)anthracene
(DMBA)-induced mammary tumor model in female SD rats. Aim 1 is designed to
compare different selenium compounds, both organic and inorganic, with
respect to their effectiveness as chemopreventive agents. Furthermore, we
are interested in finding out if the prophylactic potency of different
selenium compounds is related to the levels of selenium in the mammary
gland and blood. Aim 2 is designed to study the synergistic action of
selenium and vitamin E in the inhibition of mammary tumorigenesis. This
project is a follow-up of our previous observation that vitamin E is able
to potentiate the anticarcinogenic action of selenium. First, we plan to
find out if lower levels of vitamin E can be used without compromising its
effectiveness, and secondly, to determine if the combination of selenium
and vitamin E supplementation can obliterate the differential effect of
high-fat and low-fat diets on mammary carcinogenesis. Finally, the effects
of selenium/vitamin E supplementation on certain aspects of the host
defense system as influenced by fat intake will be evaluated. Aim 3 is
designed to delineate if the action of selenium is unique and distinct from
other synthetic phenolic antioxidants such as butylated hydroxyanisole
(BHA). The effects of selenium will be compared to some of the well known
effects of BHA, specifically the selective induction of various liver
enzymes that are responsible for the detoxification and inactivation of
xenobiotics. Aim 4 is designed to determine if selenium stimulates the DNA
repair mechanism after carcinogenic injury. We have previously
demonstrated that suppression of mammary tumorigenesis was observed when
selenium supplementation was limited to the time of carcinogen
administration. We therefore plan to examine the effect of selenium on the
binding of DMBA to mammary cell DNA and on the excision repair process as
measured by unscheduled DNA synthesis. It cannot be overemphasized that a
better understanding of the diverse action of selenium is essential before
its usefulness in chemoprevention can be properly evaluated.
该提议的目的是继续研究
硒在乳腺肿瘤中的抗癌作用并确定
高脂饮食的喂养如何改变化学预防功效
硒。 我们的调查涉及二甲基苯甲酸(a)蒽
(DMBA)在雌性SD大鼠中诱导的乳腺肿瘤模型。 AIM 1旨在
将不同的硒化合物(有机和无机化合物)与
尊重它们作为化学预防剂的有效性。 此外,我们
有兴趣找出不同的预防效力
硒化合物与乳腺中的硒水平有关
腺体和血液。 AIM 2旨在研究
硒和维生素E在抑制乳腺肿瘤发生中。 这
项目是我们以前观察到维生素E的后续行动
增强硒的抗癌作用。 首先,我们计划
找出是否可以使用较低水平的维生素E
有效性,其次是确定硒的组合是否
维生素E补充可以消除
乳腺癌发生的高脂饮食和低脂饮食。 最后,效果
在宿主的某些方面补充硒/维生素E
将评估受脂肪摄入影响的防御系统。 AIM 3是
如果硒的作用是独特的,并且不同于
其他合成酚类抗氧化剂,例如丁基化的羟基烷溶剂
(bha)。 硒的影响将与一些已知的
BHA的影响,特别是各种肝的选择性诱导
负责排毒和失活的酶
异种生物。 AIM 4旨在确定硒是否刺激DNA
致癌损伤后修复机制。 我们以前有
证明当乳腺肿瘤发生抑制时
补充硒是致癌时间的
行政。 因此,我们计划检查硒对
DMBA与乳细胞DNA和切除修复过程的结合为
通过未定义的DNA合成测量。 不能过分强调
更好地理解硒的多种作用是必不可少的
可以正确评估其在化学预防中的有用性。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
CLEMENT C IP其他文献
CLEMENT C IP的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('CLEMENT C IP', 18)}}的其他基金
Translational Research of Finasteride and Selenium Prevention of Prostate Cancer
非那雄胺和硒预防前列腺癌的转化研究
- 批准号:
7239373 - 财政年份:2007
- 资助金额:
$ 12.07万 - 项目类别:
Translational Research of Finasteride and Selenium Prevention of Prostate Cancer
非那雄胺和硒预防前列腺癌的转化研究
- 批准号:
7687536 - 财政年份:2007
- 资助金额:
$ 12.07万 - 项目类别:
Translational Research of Finasteride and Selenium Prevention of Prostate Cancer
非那雄胺和硒预防前列腺癌的转化研究
- 批准号:
7930598 - 财政年份:2007
- 资助金额:
$ 12.07万 - 项目类别:
MECHANISM OF SELENIUM POTENTIATION OF FINASTERIDE EFFICACY
硒增强非那雄胺功效的机制
- 批准号:
7254393 - 财政年份:2007
- 资助金额:
$ 12.07万 - 项目类别:
Translational Research of Finasteride and Selenium Prevention of Prostate Cancer
非那雄胺和硒预防前列腺癌的转化研究
- 批准号:
8135364 - 财政年份:2007
- 资助金额:
$ 12.07万 - 项目类别:
Selenium molecular signaling in human prostate cancer
人类前列腺癌中的硒分子信号传导
- 批准号:
7229574 - 财政年份:2003
- 资助金额:
$ 12.07万 - 项目类别:
Selenium molecular signaling in human prostate cancer
人类前列腺癌中的硒分子信号传导
- 批准号:
6897458 - 财政年份:2003
- 资助金额:
$ 12.07万 - 项目类别:
Selenium molecular signaling in human prostate cancer
人类前列腺癌中的硒分子信号传导
- 批准号:
6748976 - 财政年份:2003
- 资助金额:
$ 12.07万 - 项目类别:
Selenium molecular signaling in human prostate cancer
人类前列腺癌中的硒分子信号传导
- 批准号:
7079343 - 财政年份:2003
- 资助金额:
$ 12.07万 - 项目类别:
相似国自然基金
Tim-3,逆转CAR-T细胞耗竭的可能靶点?
- 批准号:81600120
- 批准年份:2016
- 资助金额:18.0 万元
- 项目类别:青年科学基金项目
中国健康人血液一般参考值与地理因素的关系
- 批准号:40141002
- 批准年份:2001
- 资助金额:5.0 万元
- 项目类别:专项基金项目